Boston Scientific may acquire full ownership of MiRus’ TAVR business for an additional $3bn after achieving certain ...

The deal gives Boston Scientific a 34% equity stake in MiRus and an option to acquire its TAVR platform by making additional ...

Boston Scientific (NYSE:BSX) announced today that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) ...

May 18 (Reuters) - U.S. medical device maker Boston Scientific said on Monday it has invested $1.5 billion in privately held ...

BostonSci secures rights to acquire MiRus' SIEGEL TAVR system with $1.5B equity stake and potential buyout, marking its 3rd ...

Boston Scientific recalls pacemakers due to battery issues causing safety mode activation linked to 4 deaths and 2,557 serious injuries, FDA reports.

We just covered Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and Boston Scientific Corporation (NYSE:BSX) ranks 9th on this list. Boston Scientific Corporation (NYSE:BSX) has ...

With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for ...

April 22 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab slashed its annual profit and revenue ‌growth forecasts on Wednesday, a move analysts said could reassure investors ...

The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...

April 22 (Reuters) - Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a first-quarter earnings and revenue beat, while its shares were little changed ...